On Wednesday, Shares of Denbury Resources Inc. (NYSE:DNR), added 2.52% and closed at $3.25 in the last trading session. The last trading range of the stock ranges between $3.24 and $3.40. The company’s Market capitalization is $1.25 Billion with the total Outstanding Shares of 398.33 million.Denbury Resources Inc. (DNR) (“Denbury” or the “Company”) recently declared that as part of its ongoing succession planning process, the Board of Directors has promoted Chris Kendall to President of the Company. Mr. Kendall will assume this position from Denbury’s Chief Executive Officer, Phil Rykhoek. Mr. Kendall joined Denbury as Chief Operating Officer in September 2015, and will continue to serve in that role until a successor is named.
Phil Rykhoek, CEO of Denbury commented, “The board and I congratulate Chris on this well-deserved promotion in recognition of his noteworthycontribution to our improved operations, as evidenced by our lower costs and improved efficiencies. Chris is a pleasure to work with and I anticipate that his expanded responsibilities will further enhance our continuing efforts to increase the value of the Company for our shareholders and employees.”
Hilton Worldwide Holdings Inc (NYSE:HLT), dropped -0.39% and closed at $22.74 in the last trading session. The last trading range of the stock ranges between $22.68 and $22.92. The company’s Market capitalization is $22.46 Billion with the total Outstanding Shares of 989.78 million. Hilton (HLT) recently declared its newest industry-leading family benefit, adoption assistance, offering hourly and salaried Team Members reimbursement for expenses incurred while adopting children. Hilton’s adoption assistance program will launch one year after its best-in-industry parental leave policy, and marks the leading, most comprehensive adoption assistance benefit offered in the hospitality industry.
“At Hilton, we strive to be the most hospitable company in the world, counting sharing the same hospitality with our Team Members that they provide our guests each and every day,” said Christopher J. Nassetta, president and CEO, Hilton. “Our company is committed to creating a truly great place to work that offers the benefits and rewards that matter most to our corporate and hotel Team Members at every level.”
Under the new program, Hilton will reimburse Team Members for qualified adoption expenses up to $10,000 per child, with no limit to the number of adoptions. Expenses covered include application fees, home studies, agency and placement fees, legal fees and court costs, immigration, immunization and translation fees, transportation, meals and lodging, and counseling. The benefit will take effect on January 1, 2017, and will cover all – hourly and salaried – U.S.-based Team Members who have continuously worked at Hilton for at least one year, averaging at least 30 hours per week.
Allergan plc Ordinary Shares (NYSE:AGN), lost -0.03% and closed at $235.71 in the last trading session. The last trading range of the stock ranges between $234.79 and $238.68. During the 52-week trading session the minimum price at which share price traded, registered at $195.50 and reached to max level of $322.68. A new study conducted by Econsult Solutions, Inc., a Philadelphia-based economic consulting firm, found that Allergan’s current New Jersey operations generated a combined annual economic impact in the state of $732 million. The economic impact is a direct result of the Company’s strong influence on employment in the state, generating more than 2,900 direct, indirect and induced jobs, with total employee compensation of $289 million annually.
In 2017, Allergan will combine most of its New Jersey operations, presently located in five separate locations throughout the state, into a new U.S. Administrative Headquarters in Madison, NJ. The Company will also add 300 new jobs following the combination. It is estimated that Allergan’s operations, when combined and expanded, will generate an annual economic impact of $894 million, and will support 3,700 direct, indirect and induced jobs with total employee compensation of $360 million annually.
The economic impact study, titled “The Economic Impact of Allergan’s Operations in New Jersey,” was conducted and developed by Andrea Mannino, Director and Economist at Econsult Solutions.